Mitochondrial, redox, and energy-metabolism compounds.

Mitochondrial and energy research compounds include AMPK activators, NAD+-pathway compounds, NNMT inhibitors, and mitochondrial uncouplers studied in preclinical research models for cellular bioenergetics and metabolic pathway research. The Nexus catalog includes 3 compounds in this category — examples: 5-amino-1mq, Glutathione, AICAR. Supplied for in-vitro research use only. Mitochondrial and energy research products are organized around cellular energy metabolism, redox workflows, and metabolic activation models. Nexus separates this page from longevity because the primary comparison point is energy pathway research. This category includes 5-Amino-1MQ, Glutathione, and AICAR. Product pages focus on compound identity, variant data, and lab-tested context rather than outcome claims.

Researchers in this category often compare redox state, cellular energy pathways, and metabolic signaling context. The products are not all peptides, but they share a research-discovery pattern around energy and cellular metabolism. Nexus keeps the category practical: users can compare products, inspect COA links, and move into related cellular-health pages when the study intent overlaps with longevity or mitochondrial peptide research.

Nexus emphasizes batch visibility, product identity, and HPLC or COA context where available. Copy avoids supplement-style claims and stays within research catalog boundaries.

Compounds in this category are studied in preclinical research models examining cellular bioenergetics, AMP-activated protein kinase (AMPK) pathway research, NAD+ pathway research, nicotinamide N-methyltransferase (NNMT) inhibition research, and mitochondrial uncoupler pharmacology. Common research applications include AICAR research on AMPK pathway activation, 5-Amino-1MQ research as an NNMT inhibitor affecting the NAD+ pool, and glutathione research as a redox-pathway research reference.

The three compounds span small-molecule mitochondrial research targets: AICAR (5-aminoimidazole-4-carboxamide ribonucleotide, an AMPK pathway research compound), 5-Amino-1MQ (NNMT inhibitor research compound), and glutathione (γ-glutamyl-cysteinyl-glycine, the canonical redox research peptide). None are peptide hormones; all three are small molecules or short tripeptides with non-receptor mechanisms.

Cross-category research-stack pairings: 5-Amino-1MQ + NAD+ (in Longevity) for NAD+-pathway research; AICAR + NAD+ for AMPK + NAD+ combined research; AICAR + BAM15 (in Oral Tablets) for AMPK + mitochondrial-uncoupler research; glutathione + NAD+ for redox-research pairings.

AICAR (~259 Da) and 5-Amino-1MQ (~158 Da) are small molecules characterized by HPLC + UV spectroscopy and ESI-MS. Glutathione (~307 Da) is a tripeptide characterized by HPLC + MS. Finalized COA records apply analytical chemistry appropriate to each structural class; pending lots are labeled certificate pending.